| TSCO |
Report |
Comp SSS (Q2 2026) |
BEAT |
pred ~1.2% vs cons 0.03% |
MEDIUM |
| TSCO |
Report |
EPS-Diluted (Q2 2026) |
BEAT |
pred ~$0.84 vs cons $0.823 |
MEDIUM |
| TSCO |
Report |
Net Sales (Q2 2026) |
IN-LINE |
pred ~$4.63B vs cons $4.592B |
MEDIUM |
| TSCO |
Guide |
FY 2026 EPS (FY 2026) |
BETTER |
guide ~$2.18 mid vs cons $2.046 |
MEDIUM |
| TSCO |
Guide |
FY 2026 Comp SSS (FY 2026) |
BETTER |
guide floor ~1% vs cons 0.45% |
MEDIUM |
| TSCO |
Guide |
H2 Gross Margin Direction |
UNCHANGED |
Reaffirm H2 expansion; DC on track |
HIGH |
| TSCO |
Return |
Day-1 residual (stock − beta × S&P 500) |
+1.5% |
— |
MEDIUM |
| TSCO |
Return |
5-day cumulative residual |
-2.0% (FADE) |
FADE — estimates partially revise up but not to guidance midpoint; pet structural overhang and Street credibility gap persist |
MEDIUM |